A generic-mifepristone maker sued the U.S. Food and Drug Administration to protect access to the medical abortion pill amid a welter of litigation stretching from Texas to Washington.
The lawsuit by GenBioPro Inc., filed Wednesday in federal court in Maryland, comes as the U.S. Supreme Court delayed until Friday a decision on which restrictions on the pill will remain in place after a federal judge in Texas blocked the FDA’s approval of mifepristone in a separate lawsuit.
GenBioPro makes most of the mifepristone sold in the U.S. It says in its suit that if the FDA is forced to comply with the Texas court order, the drug maker would face “imminent, catastrophic, and irreparable harm.”
